Mayo Clinic researchers and collaborators have identified key clinical findings that can help clinicians recognize patients with potentially treatable causes of rapidly progressive dementia, who[...]
In a new study published in Circulation: Genomics & Precision Medicine, Mayo Clinic researchers designed and developed the first suppression-replacement KCNH2 gene therapy for correcting both long QT syndrome[...]
Every year, more than 130,000 people in the U.S. are diagnosed with end-stage kidney disease, with most cases caused by diabetes. Newer therapies show promise[...]
In a new study, Mayo Clinic researchers identified substantial health disparities in rural versus urban areas in diabetes-related deaths, with other disparities based on gender. Using[...]
No posts available.
For Journalists Only Sign up for a Journalist Pass
An online patient support community